Based in Heidelberg, we invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment modalities and pharmaceuticals, next generation enabling technology platforms or innovations in the diagnostics and medical device area. Besides our investment activities, we offer consulting to life science companies with a focus on company building, M&A, corporate strategy as well as in- and out-licensing. Our team has a significant scientific and life science industry related network, a strong investment track record as well as experience in building successful companies, closing collaboration- and licensing agreements, M&A's and IPOs.
18
Total Investments
11
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About EMBL Ventures
Recent Investments (18)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Jul 2021 | |
| Series B | •••••• | Oct 2020 | |
| Series B | •••••• | Apr 2018 | |
| Series D | •••••• | Apr 2017 | |
| Series A | •••••• | Jan 2017 | |
|
|
Series B | •••••• | Jun 2016 |
|
|
Series A | •••••• | Mar 2016 |
|
|
Series A | •••••• | Oct 2015 |
|
|
Series A | •••••• | Jun 2015 |
|
|
Spinout | •••••• | May 2015 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.